Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  NextGen Healthcare, Inc.    NXGN

NEXTGEN HEALTHCARE, INC.

(NXGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 8701 089686988--
Entreprise Value (EV)1 8781 067677871888864
P/E ratio 341x44,3x94,9x157x63,2x46,4x
Yield ------
Capitalization / Revenue 1,64x2,06x1,27x1,83x1,75x1,69x
EV / Revenue 1,65x2,02x1,25x1,61x1,57x1,48x
EV / EBITDA 10,4x13,4x6,66x9,04x8,46x7,60x
Price to Book 2,70x2,90x1,72x2,40x2,40x2,41x
Nbr of stocks (in thousands) 63 71464 69765 70166 669--
Reference price (USD) 13,716,810,414,814,814,8
Last update 05/24/201805/28/201906/01/202007/31/202007/31/202007/31/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 531529540540565585
EBITDA1 84,379,510296,4105114
Operating profit (EBIT)1 2,8231,65,1115,430,832,0
Operating Margin 0,53%5,98%0,95%2,84%5,46%5,46%
Pre-Tax Profit (EBT)1 -0,4129,34,2613,330,037,1
Net income1 2,4224,57,506,1716,021,5
Net margin 0,46%4,63%1,39%1,14%2,83%3,67%
EPS2 0,040,380,110,090,230,32
Dividend per Share2 ------
Last update 05/24/201805/28/201906/01/202007/14/202007/14/202007/14/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 8,16-----
Net Cash position1 -22,19,0111799,6124
Leverage (Debt / EBITDA) 0,10x-0,28x-0,09x-1,21x-0,95x-1,09x
Free Cash Flow1 47,925,058,736,648,434,3
ROE (Net Profit / Equities) 14,2%16,0%14,1%6,55%9,18%14,8%
Shareholders' equity1 17,115353,394,2174145
ROA (Net Profit / Asset) 9,00%10,6%1,20%3,92%3,96%0,55%
Assets1 26,92306271574033 939
Book Value Per Share2 5,055,806,066,176,166,14
Cash Flow per Share2 -0,781,30-1,711,450,49
Capex1 28,725,526,926,729,331,9
Capex / Sales 5,40%4,82%4,98%4,93%5,19%5,45%
Last update 05/24/201805/28/201906/01/202008/04/202008/04/202008/04/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
988 039 915
Net sales (USD)
540 239 000
Number of employees
2 754
Sales / Employee (USD)
196 165
Free-Float
81,3%
Free-Float capitalization (USD)
803 422 670
Avg. Exchange 20 sessions (USD)
5 649 333
Average Daily Capital Traded
0,57%
EPS & Dividend